[
  {
    "ts": null,
    "headline": "Quest Diagnostics Inc. stock underperforms Monday when compared to competitors despite daily gains",
    "summary": "Quest Diagnostics Inc. stock underperforms Monday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=f970edcea84cea11c396c65a2bb880d77e05f134c1d1b8f71c389873d7aa2164",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731345120,
      "headline": "Quest Diagnostics Inc. stock underperforms Monday when compared to competitors despite daily gains",
      "id": 131430820,
      "image": "",
      "related": "DGX",
      "source": "MarketWatch",
      "summary": "Quest Diagnostics Inc. stock underperforms Monday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=f970edcea84cea11c396c65a2bb880d77e05f134c1d1b8f71c389873d7aa2164"
    }
  },
  {
    "ts": null,
    "headline": "DGX vs. PNTG: Which Stock Is the Better Value Option?",
    "summary": "DGX vs. PNTG: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=f613fc95d39a66e88e71dffc6569a76631e0a2ab42e108ef0357e65194c9f743",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731343216,
      "headline": "DGX vs. PNTG: Which Stock Is the Better Value Option?",
      "id": 131303763,
      "image": "https://media.zenfs.com/en/zacks.com/3496571a811465d910e99bd171c71a94",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "DGX vs. PNTG: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=f613fc95d39a66e88e71dffc6569a76631e0a2ab42e108ef0357e65194c9f743"
    }
  },
  {
    "ts": null,
    "headline": "INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up",
    "summary": "Inogen's overall third-quarter 2024 results continue to gain from higher business-to-business sales.",
    "url": "https://finnhub.io/api/news?id=5353cdc6762f185242b97286b4c5c4a16c984c06a7b2ce60bcd7ed2ed0575f40",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731339000,
      "headline": "INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up",
      "id": 131287037,
      "image": "https://media.zenfs.com/en/zacks.com/32e3eb8c0cc46c163964cde251fb4426",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Inogen's overall third-quarter 2024 results continue to gain from higher business-to-business sales.",
      "url": "https://finnhub.io/api/news?id=5353cdc6762f185242b97286b4c5c4a16c984c06a7b2ce60bcd7ed2ed0575f40"
    }
  },
  {
    "ts": null,
    "headline": "BRKR Stock Declines Despite Launching EpicIF Technology for CellScape",
    "summary": "Bruker's new technology, EpicIF, is set to enhance the CellScape Precise Spatial Proteomics platform.",
    "url": "https://finnhub.io/api/news?id=4914d0b3f5d22b5af699500c0b8a718252894d48364362f4c202146c60834c85",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731338760,
      "headline": "BRKR Stock Declines Despite Launching EpicIF Technology for CellScape",
      "id": 131287238,
      "image": "https://media.zenfs.com/en/zacks.com/a1d7049b0977a02a21fd2aa02b46f307",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Bruker's new technology, EpicIF, is set to enhance the CellScape Precise Spatial Proteomics platform.",
      "url": "https://finnhub.io/api/news?id=4914d0b3f5d22b5af699500c0b8a718252894d48364362f4c202146c60834c85"
    }
  },
  {
    "ts": null,
    "headline": "AMED Q3 Earnings and Revenues Miss, Margins Dip, Stock Falls",
    "summary": "Amedisys, for the third quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care.",
    "url": "https://finnhub.io/api/news?id=d18e444a7f7118911cab74a40a16ceff25f0701bfd9187980050f416fcb8c76f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731332400,
      "headline": "AMED Q3 Earnings and Revenues Miss, Margins Dip, Stock Falls",
      "id": 131285731,
      "image": "https://media.zenfs.com/en/zacks.com/0e6e00119767dea571e2db52c929df03",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Amedisys, for the third quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care.",
      "url": "https://finnhub.io/api/news?id=d18e444a7f7118911cab74a40a16ceff25f0701bfd9187980050f416fcb8c76f"
    }
  },
  {
    "ts": null,
    "headline": "Haemonetics' Q2 Earnings and Revenues Top, Stock Up, Margins Expand",
    "summary": "HAE delivers impressive growth in the top and bottom lines in the second quarter of fiscal 2025.",
    "url": "https://finnhub.io/api/news?id=8b7291ff675ce11de52f266359e3fddbab305f18cef6644c20f169a253c0f3da",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731329820,
      "headline": "Haemonetics' Q2 Earnings and Revenues Top, Stock Up, Margins Expand",
      "id": 131287241,
      "image": "https://media.zenfs.com/en/zacks.com/3136c22cf05e163ab2bb94a2755707e9",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "HAE delivers impressive growth in the top and bottom lines in the second quarter of fiscal 2025.",
      "url": "https://finnhub.io/api/news?id=8b7291ff675ce11de52f266359e3fddbab305f18cef6644c20f169a253c0f3da"
    }
  }
]